digestive/alimentary system
|
• following tamoxifen treatment a marked expansion of the proliferative compartment is seen
|
|
• following tamoxifen treatment a marked expansion of the proliferative compartment is seen with enlarged crypts and Ki67+ cells ectopically located on the flanks of villi
• increase in the number of Olfm4+ stem cells after tamoxifen treatment
|
|
• increased number after tamoxifen treatment
|
|
• form within 1 month of clonal deletion induced by low dose tamoxifen treatment
• contain Olfm4+ stem cells and Paneth cells
|
neoplasm
|
• form within 1 month of clonal deletion induced by low dose tamoxifen treatment
• contain Olfm4+ stem cells and Paneth cells
|
cellular
|
• following tamoxifen treatment a marked expansion of the proliferative compartment is seen
|
endocrine/exocrine glands
|
• following tamoxifen treatment a marked expansion of the proliferative compartment is seen with enlarged crypts and Ki67+ cells ectopically located on the flanks of villi
• increase in the number of Olfm4+ stem cells after tamoxifen treatment
|
|
• increased number after tamoxifen treatment
|